Insurers Claim AI Coding Tools Added $942M to Healthcare Costs

The Blue Cross Blue Shield Association (BCBSA) analysis found a sharp increase in patients being documented as having complex medical conditions, but argued there is a clear disconnect between medical coding and actual treatment. “There’s no evidence of corresponding change in care delivered,” the association said.

The findings, reported by The New York Times, add to a growing debate over whether AI is inflating healthcare expenses. While disputes between hospitals and insurers over treatments and payments are not new, the use of artificial intelligence on both sides appears to be intensifying the conflict.

Dr. Shiv Rao, founder of AI startup Abridge, acknowledged the potential for an adversarial future. AI could lead to “a horrible dystopic future nobody wants to live in,” he said, describing a scenario of “bots fighting bots, agents fighting agents.” However, Rao suggested that AI might also eventually reduce tensions and lower costs if used constructively.

BCBSA senior vice president Luke Chalker was less diplomatic. Rejecting the characterisation of the situation as a war, he called it “a completely one-sided blood bath,” with insurers on the losing side.

Why This Matters

The additional $942 million in spending could translate into higher premiums for employers and individuals as insurers seek to recover costs.
If AI-assisted upcoding becomes widespread without genuine improvements in care, it could undermine trust in both artificial intelligence and the healthcare billing system.
The dispute highlights a growing arms race in which hospitals and insurers deploy AI against each other, raising questions about regulatory oversight.

Background

Artificial intelligence is increasingly used in medical coding to analyse patient records and suggest diagnosis codes for insurance claims. Hospitals argue that these tools capture the true complexity of patient conditions and justify appropriate reimbursement. Insurers counter that the software is being used to inflate billing without altering the actual care provided. The BCBSA analysis is one of the first large-scale attempts to quantify the financial impact of this practice.

Key Perspectives

Insurers (BCBSA): They view AI adoption by hospitals as a cost-driver that produces higher claims without corresponding medical justification. Luke Chalker described the situation as one-sided in favour of providers. Hospital systems and AI vendors: Proponents argue that AI improves accuracy in coding and can eventually streamline administrative overhead. Dr. Shiv Rao of Abridge acknowledged risks but also saw potential for AI to reduce tensions and cut costs if deployed collaboratively. Critics/Skeptics: The lack of evidence linking increased coding to changes in treatment suggests that AI may be gaming the system rather than improving health outcomes, potentially leading to stricter regulation or payment reforms.

What to Watch

Whether state or federal regulators investigate AI-assisted coding practices and issue guidance on appropriate use.
The release of further data from insurers or independent researchers on whether patient outcomes correlate with the new coding patterns.
The response from hospital associations and AI vendors, who may push back against the BCBSA’s methodology or conclusions.

ZOTPAPER